ArticleBMJ open2026
Health databases and early identification of autism spectrum disorder: a scoping review.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo map the available evidence on the use of health databases for the early identification of autism spectrum disorder (ASD) across diverse populations and settings.
designScoping review conducted in accordance with the Joanna Briggs Institute framework. DATA SOURCES: Searches were conducted in MEDLINE, Embase, Scopus, PsycINFO, Web of Science and Latin American and Caribbean Health Sciences Literature, with grey literature searched through ProQuest Dissertations and Theses, up to December 2024, and updated on March 2026. ELIGIBILITY CRITERIA: Studies including individuals with diagnosed or suspected ASD were considered without restrictions on age, country or healthcare setting. Early identification was defined as the detection of ASD-related features prior to formal diagnosis. Health databases included digital sources such as electronic health records and surveillance systems, excluding those based solely on biological or genetic data. DATA EXTRACTION AND SYNTHESIS: Study selection and data extraction were performed independently by two reviewers. Extracted data were synthesised descriptively according to database type, analytical methods and reported outcomes.
resultsThirty-seven studies were included, mostly from high-income countries and involving children or adolescents. Data sources included electronic medical records (n=25), automated healthcare databases (n=6) and national surveys or data sets (n=6); only one database was publicly accessible. Analytical methods comprised machine learning (ML) (n=14), predictive modelling (n=6), natural language processing (NLP) (n=7) and diagnostic code algorithms (n=7). Common early predictors reported across studies include male sex, advanced maternal age, immigrant background, low SES, perinatal complications, and language or motor delays. Reported comorbidities included epilepsy, attention-deficit/hyperactivity disorder, mood/anxiety disorders and sensory issues. Children later diagnosed with ASD had more frequent medical visits, hospitalisations and emergency care. Diagnostic delays were more pronounced among low-income and underrepresented groups, despite early parental concerns.
conclusionHealth databases have been increasingly used to support early ASD detection through methods like ML and NLP; however, their clinical application is limited by challenges related to standardisation, ethical considerations, feasibility and data access. Addressing these barriers is essential to support inclusive, evidence-based strategies. TRIAL REGISTRATION NUMBER: Open Science Framework. DOI: 10.17605/OSF.IO/RMVWE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.